chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Uncontrollable chills, tremors; Myalgias; Fatigue; Low-grade fever; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CHILLS (Uncontrollable chills, tremors), MYALGIA (Myalgias), FATIGUE (Fatigue) and PYREXIA (Low-grade fever) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in April 2020.    On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Dec-2020, the patient experienced CHILLS (Uncontrollable chills, tremors), MYALGIA (Myalgias), FATIGUE (Fatigue) and PYREXIA (Low-grade fever). At the time of the report, CHILLS (Uncontrollable chills, tremors), MYALGIA (Myalgias), FATIGUE (Fatigue) and PYREXIA (Low-grade fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported. The patient reported that it was severe, much more severe than when she had COVID19. It lasted for 30 hours.
For two days:  101 degree fever, bad headache, muscle aches -- severe enough I had to cancel monthly meetings.
Stroke like symptoms consisting of facial asymmetry & slurred speech. Patient sent to stroke facility w/ Neurology services.
This case was reported by a consumer via call center representative and described the occurrence of headache in a adult female patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. In April 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced headache, sore throat, upset stomach, feeling bad and product supply issue. On an unknown date, the outcome of the headache, sore throat, upset stomach, feeling bad and product supply issue were unknown. It was unknown if the reporter considered the headache, sore throat, upset stomach and feeling bad to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient did not remember the exact date of her 1st vaccination but thought it was in April.  She said she felt lousy, which included a headache, sore throat and upset stomach. However she did not remember how soon after the vaccine she developed these symptoms. The patient had denied permission to contact their physician. She called because of the availability issue of the SHINGRIX.
Resting heart rate over 150 for more than 2 hours, while sleeping.  Fever of 103.8 after taking Tylenol. Hard, itchy, hot bump at injection sight.  Super achy and sweating profusely.  Called Covid hotline and was told to call my GP. Called and was instructed to take 800 mg of ibuprofen and call back in an hour to report fever. Called back and fever had gone down to 102.2. Was told to wait another 30 mins.  and if fever hasn?t gone down to go to the hospital. Was told to go to the hospital as well, if my heart rate didn?t go down.
DIFFICULTY BREATHING; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 01-SEP-2021 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On 01-SEP-2021, the patient experienced difficulty breathing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of difficulty breathing was not reported. This report was non-serious.
I tested positive on Monday for the COVID-19;  I got my booster and everything back in Aug; I tested positive on Monday for the COVID-19;  I got my booster and everything back in Aug; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and in Aug2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (ongoing), notes: I do have Asthma. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "I tested positive on Monday for the COVID-19;  I got my booster and everything back in Aug". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Nov2022) Positive, notes: I tested positive on Monday for the COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient called because patient tested positive on Monday for the COVID-19 (Captured conservatively). This is the second 'dose', is it. I got it an year ago. I got my booster and everything back in August. So I have done everything, so I do have Asthma (Intent: Medical history) and all of that but my doctor put me on Paxlovid on Wednesday. I took two days' worth, but on the very first dose almost immediately, I noticed a funny taste in my mouth and I have not been able to get rid of it. It's just like on my tongue, it's just bad taste. I just thought, I don't know what it is. It's not like, I ever lost my sense of taste with Covid or anything like that. I have a decent appetite but I can't get rid of this awful taste and I can't help but think, Is this is Paxlovid? I mean, I brush my teeth and everything and I cannot get rid of the, it's just an awful taste. It taste like, I had a bad, bad medicine. It's just gross and I didn't take my this morning dose. Yeah, I just don't want to take it. It's taste like I have really bad breath or something, it's hideous. So I don't know if it have to do with the Paxlovid. Well, I wanted to know if this is a side effect of the Paxlovid."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a health professional concerning a female patient who was vaccinated with a dose of GARDASIL. Subsequently the patient experienced granuloma annulare. The patient's outcome at the time of the report was unknown. The patient sought medical attention through an office visit. Additional information is not expected.
At exactly two weeks after my COVID19 booster vaccine, I had a sudden onset of urticaria and dermatographia all day. To this date, the urticaria and dermatographia are chronic. The only treatment is to take Allegra 180mg daily.  When this first happened, I was taking Zyrtec once a day for help, and if I missed a dose the symptoms would reappear after the last dose wore off. I finally found my way to an allergy doctor in April of 2022 after my booster in December of 2021. The doctor advised me to switch to Allegra four times a day and Pepcid twice a day, and to slowly titrate down to just Allegra once a day. I have since July 2022, been taking Allegra only, but have been unable to skip a dose.
zoster Recomb vent,  Very tired,  2 naps,  x tra 6 hours , redness at sight, slight headache
DVT and PE  Symptoms of RLE pain started 10 days ago (around 2/14 or about 3 weeks after his second COVID shot in initial series)
the reporter stated that several pt devel inj site rxn characterized by redness, itching, & swelling w/in 3 hr of vax;
Throat swollen; tingling sensation; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Throat swollen), PARAESTHESIA (tingling sensation) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included No adverse event.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PHARYNGEAL SWELLING (Throat swollen), PARAESTHESIA (tingling sensation) and NAUSEA (nausea). At the time of the report, PHARYNGEAL SWELLING (Throat swollen), PARAESTHESIA (tingling sensation) and NAUSEA (nausea) outcome was unknown.            Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
since the administration of the second dose she's been having worsening memory loss issues; really progressing badly; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 45 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "anxiety" (unspecified if ongoing), notes: she thinks the patient has a little anxiety but it is nothing that was diagnosed medically with depression.; "Fibromyalgia" (ongoing), notes: This was diagnosed probably prior to the Pfizer COVID vaccine. There were no concomitant medications. Vaccination history included: Bnt162b2 (Prior Vaccinations (within 4 weeks): None other than 1st dose Pfizer COVID vaccine administered Feb2021.), administration date: Feb2021, when the patient was 45 years old, for COVID-19 immunization. The following information was reported: AMNESIA (non-serious), outcome "not recovered", described as "since the administration of the second dose she's been having worsening memory loss issues"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "really progressing badly".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Severe pain at injection site beginning 1 hour post injection.   General loss of motor function in entire arm.    Symptoms worse after 24 hours.
1 of 5 pts immunized who exp a nodule @ the DTP inject site; also had 1-22" area of induration & erythema; event occurred in pt w/in 48 hrs of vax;
PINK, WARM RAISED AREA WITH IRREGULAR BORDER. WARM TO TOUCH. PT DENIES ITCHING OR PAIN.  TX: ICED AND TAKING IBUPROFEN OUTCOME: RECOMMENDED TO GO TO URGENT CARE/ER TO RULE OUT ANAPHYLAXIS
Cold/flu-like overnight 12 hours after vaccine, fading later in the day.  Symptoms increased the next night, increasing each day to peak on day 8 (02/19/2021. Symptoms gradually decreased thereafter until 02/26/2021 at the time of this note. Symptoms are now very minor residual intranasal congestion and slightly more significant chest congestion. Symptom trajectory started as rhinorrehia and pronounced nasal congestion that partially responded to decongestants and improved more with nasal fluticasone. Bronchial congestion began after on day 3 to 4, with shortness of breath experienced overnight (never before experienced). Remarkable, intense aerobic exercise was done with no difficulty during the day, with some moderation taken on 02/19/2021. Fatigue did affect daily activities, but not dramatically. That this was a vaccine side effect signal is clear to me.
Cannot control himself; Face feels hot; loss of control of legs/cannot control himself/gait inability; shaking with chills; A spontaneous report was received from a consumer concerning a 83-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events of cannot control himself (loss of control of legs), hard to walk (gait inability), shaking with chills (chills), face feels hot (hot flush).  The patient's medical history and concomitant medications was not provided.   On 17Feb2021, the day before the onset of the events, the patient received first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 18Feb2021, the patient experienced not controlling himself. He reported it was hard to walk, he was shaking with chills, had three coats on and his face felt hot. Additionally he reported he was on the floor because he was nervous he was going to fall. The patient's granddaughter came to his house and he tried to call his physician but was unsuccessful as his physician was not available. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, were considered as unknown.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
severe and long lasting pain in hip flexors Still occurring as of today 7/14/2021
patient was administered expired acthib with no reported adverse event; Initial information received on 08-Dec-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 14 months old male patient to whom expired HIB (PRP/T) vaccine [ACT-HIB] was administered with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included measles vaccine, mumps vaccine, rubella vaccine (MMR) for Prophylactic vaccination(immunization).  On 07-Dec-2022, the patient received 0.5 ml(milliliter), 1x(once)(dose 4) of suspect HIB (PRP/T) vaccine, Powder and solvent for solution for injection (lot UJ614ABA)(expiry date: 30-Nov-2022) (with unknown  dose) via intramuscular route in the left thigh for immunization.  On 07-Dec-2022, patient received expired HIB (PRP/T) vaccine with no reported adverse event (expired product administered) (latency: same day).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
About 5 minutes after receiving the vaccine, patient was sitting down, and started to feel nauseous, pale, and dizzy. We had the patient lie down on her back and elevate her legs, place a cold compress on her forehead. Within 2-3 minutes, patient was feeling better. She sat around for another 15 minutes and then left after feeling fine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 83-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 83 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Arteriosclerosis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that patient received Paxlovid for treatment of COVID-19 which stopped on. 13Apr2023. No known allergies were reported.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Client was intended to receive a dose of Janssen Johnson and Johnson COVID vaccine. The client was accidentally given a dose of Pfizer COVID vaccine LOT FF8839 instead. Client was informed of medication error and instructed to return in 3 weeks for additional dose in order to receive full coverage. Client denied any allergies or medical conditions that would be contraindicated to receive Pfizer. Client educated on ED precautions. Client stayed for a15 minute observation without incidence and left the site on his own accord and with a steady gait.
Pt stated feeling "quesy and some nausea". Hx: HTN. 11:05 BP:117/60, P:84, Spo2: 98% RA. 1124: Pt stated "feeling much better, ready to go". BP: 119/66, P:84, Spo2: 98% RA. Pt instructed to stay hydrated and to call PCP if stmptoms return. 1129: Pt released.
Information has been received from a nurse practitioner concerning a 61 years old female with hypertension and drug allergies to penicillin, cephalosporin and sulfa who on 10-MAY-2011 was vaccinated subcutaneously with a dose of ZOSTAVAX (Merck) (lot#669865/0362AA) (Expiration: 09-JUN-2012) in the right arm. Concomitant therapy included DIOVAN, TOPROL XL Tablets, LIPITOR, hydrochlorothiazide (manufacturer unknown) and ADACEL. The nurse practitioner reported that she experienced exacerbation of post herpetic neuralgia after administration of ZOSTAVAX (Merck). She was administered ADACEL during the same visit. In January of 2011 she developed zoster on her scalp and later experienced post herpetic neuralgia which lasted until beginning of March of 2011. On 14-MAY-2011, she was experiencing mild pain and discomfort at the same location on the left side of her scalp The patient was not constant. It waxed and waned. She stated on a scale of 1 to 10 her pain was a 1. No treatment was given. The patient sought medical attention via phone. There was no lab diagnostics performed. At the time of the report, the patient had not recovered. No further information is available.
Arrhythmia or tachycardia, imbalance, heaviness in the head and I have a stiff neck.
Axillary swelling, painless, began ~24 hours after immunization, most severe x 2 days, nearly resolved at the time of the visit.
Fever; Runny nose; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative. The reporter is the patient.  A 25-year-old patient received BNT162b2 (BNT162B2), on 16Jun2021 as dose 2, single (Batch/Lot number: unknown) at the age of 25 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE), administration date: 25May2021, when the patient was 25-year-old, for COVID-19 immunization, reaction(s): "Fever", "Runny nose". The following information was reported: PYREXIA (non-serious) with onset 2021, outcome "unknown", described as "Fever"; RHINORRHOEA (non-serious) with onset 2021, outcome "unknown", described as "Runny nose".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt recvd vax 4SEP91 taken by life flight 9SEP91to hosp had viral meningitis; dx not caused by immun; recvd vax 4MAR; had rash on stomach; 8MAR shoulder pink, red bumpy, red rash used aristocort A; ? temp; 11MAR big red blotch under skin;
nausea/vomiting, fever/chills,  fatigue, malaise, body aches. following the dose #2. Patient woke up 48 hours after vaccine with a diffuse res, flat patchy warm rash to the left upper arm. The area is sore to touch. Four days after the vaccine the rash persists, other symptoms have improved but not fully resolved.
pt had a positive COVID test on 12/6/21; asymptomatic except for poor oral intake; pt stays in Health and Rehab facility; pt passed away in the facility; DC and med records sent.
1120 pt reports dizziness after vaccine. pt cool, clammy, nauseated, bp 72/35, team called. pt transferred to observation area, lying down on gurney. ER staff present. Mother reports pt did not eat breakfast this am. Apple juice given. 1135 pt reports improvement in symptoms, bp 106/56, dc home in stable condition.
Starting having chest pain 5 minutes after shot. they are very sharp and a tightness in my chest.  It has been on and off for five days now.
Patient has experienced the shingles a month later of getting the vaccine, Patient is on Valacyclovir and Prednisolone AC eye drops.
Fever for about 26 hours (between 99.9 to 101.1).
Patient said she had a "slight sore throat" the day after her first dose. She said by the second day, it "lightened up into nothing".
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. In December 2013 the patient was vaccinated with GARDASIL (dose strength was not reported) dose 1, intramuscular. On 28-APR-2014 the patient was vaccinated with GARDASIL dose 2, intramuscular. No concomitant medication was reported. No adverse effect reported. No product quality complaint was reported. The outcome of patient received her first dose of GARDASIL in December 2013 and her second dose 28-APR-2014 was unknown. Additional information has been requested.
Strong right-side abdomenal pain for several hours.  Subsided by Saturday morning on awakening.
Doses administered after 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day use by date) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day use by date) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was reported by the reporter. No concomitants medicines were reported.
Within a week after my flu shot, I started to notice a bump on my arm that wasn't going away.  It was a small nodule under the skin that was sore to touch.  Over time it has continued to get larger and it is now red and tender all of the time several months after the shot.
On day 8 (March 11th), I developed a red rash around the injection site.  It started at about 1.5 inches in diameter and eventually grew to 3 inches in diameter by March 15th, before subsiding.  The area was located at the injection site and felt warm and itchy.  It lasted for about a week (until March 18th).  Also, around day 6, it began hurting under my left armpit when I moved my arm. I believe it had to do w/ lymph nodes swelling.  This also subsided around the same time as the rash (~March 18th).